Investor Relations
Overview
MiMedx Group, Inc. (OTCBB: MDXG) is an integrated developer, manufacturer and marketer of patent protected and proprietary biomaterial-based products. These include our collagen fiber technology and durable hydrogel implants. The Company is positioned for rapid growth in revenues and profits once our products are introduced into the market.
Utilizing our novel materials and techniques, our products will be implants intended to competitively address a broad range of acute and chronic musculoskeletal diseases and disorders in the spine, orthopedic, and general surgery marketplace.
The markets for the specific indications our products will address is large and projected to grow at a compound annual rate of over 20% a year through 2025.
The primary factors supporting our goal of long term growth and success include:
- Patent portfolio of 8 issued and 33 pending patents
- Experienced Management
- Seasoned and Successful Board
- Renowned Physician Opinion Leaders
- Increasing expectations that people will live active lives, for longer
- Innovative technologies that expand the market
- Partnerships and technology acquisitions
Click here for Corporate Presentation
Recent Press Releases
Jan 6, 2010
MiMedx Group Announces Over-Subscription of $5,000,000 Private Placement
Dec 23, 2009
MiMedx Group Announces Launch of its Paradis Vaso Shield(TM) Device